WHA74

Geneva

Agenda

1
Item name
Opening of the meeting and adoption of the agenda
2
Item name
Report of the Executive Board on its 147th and 148th sessions, and on its special session on the COVID-19 response
3
Item name
Address by Dr Tedros Adhanom Ghebreyesus, Director-General2
4
Item name
Invited speaker(s)
5
Item name
Admission of new Members and Associate Members [if any]
6
Item name
Executive Board: election
7
Item name
Awards
8
Item name
Reports of the main committees
9.
Item name
Closure of the Health Assembly
10
Item name
Opening of Committee A
11
Item name
Proposed programme budget 2022–2023
12
Item name
WHO results framework: an update
13
Item name
Review of and update on matters considered by the Executive Board
13.1
Item name
Global action on patient safety
13.2
Item name
Political declaration of the third high-level meeting of the General Assembly on the prevention and control of non-communicable diseases: oral health
13.3
Item name
Expanding access to effective treatments for cancer and rare and orphan diseases, including medicines, vaccines, medical devices, diagnostics, assistive products, cell- and gene-based therapies and other health technologies; and improving the transpa
13.4
Item name
Global strategy and plan of action on public health, innovation and intellectual property
13.5
Item name
Antimicrobial resistance
13.6
Item name
Substandard and falsified medical products
13.7
Item name
Standardization of medical devices nomenclature
13.8
Item name
Immunization Agenda 2030
13.9
Item name
Integrated people-centred eye care, including preventable vision impairment and blindness
14
Item name
Health in the 2030 Agenda for Sustainable Development
15
Item name
Health workforce
16
Item name
Public health emergencies: preparedness and response
16.1
Item name
COVID-19 response
16.2
Item name
Independent Oversight and Advisory Committee for the WHO Health Emergencies Programme
16.3
Item name
WHO’s work in health emergencies
16.4
Item name
Implementation of the International Health Regulations (2005)
17
Item name
Mental health preparedness for and response to the COVID-19 pandemic
18
Item name
The public health implications of implementation of the Nagoya Protocol
19
Item name
Enhancement of laboratory biosafety
20
Item name
Poliomyelitis
21
Item name
Review of and update on matters considered by the Executive Board
21.1
Item name
Social determinants of health
22
Item name
Committing to implementation of the Global Strategy for Women’s, Children’s and Adolescents’ Health (2016−2030)
23
Item name
WHO global plan of action to strengthen the role of the health system within a national multisectoral response to address interpersonal violence, in particular against women and girls, and against children
24
Item name
Opening of Committee B
25
Item name
Health conditions in the occupied Palestinian territory, including east Jerusalem, and in the occupied Syrian Golan